SCHEMBL2490867

SCHEMBL2490867

FC(F)(F)c1cccc(-c2csc(Cl)n2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
AR P10275 1/20 0.59
KDM4E B2RXH2 1/20 0.59
ALDH1A1 P00352 1/20 0.59
CFTR P13569 2/20 0.54
CASP3 P42574 2/20 0.53
CASP7 P55210 1/20 0.53
CASP8 Q14790 1/20 0.53
VCP P55072 1/20 0.52
ADAM17 P78536 1/20 0.52
IDO1 P14902 1/20 0.51
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
CTSS P25774 1/20 0.49
MAPT P10636 2/20 0.48
KDM1A O60341 2/20 0.48
LTA4H P09960 1/20 0.48
MAPK1 P28482 2/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL474410 0.83 LTA4H (0.67) MEN1KMT2AARKDM4EALDH1A1
SCHEMBL28743338 0.83 ALDH1A1 (0.71) MEN1KMT2AARKDM4EALDH1A1
SCHEMBL1198896 0.83 ALDH1A1 (0.56) MEN1KMT2AARKDM4EALDH1A1
Bromide SCHEMBL8357468 0.81 LTA4H (0.65) MEN1KMT2AARKDM4EALDH1A1
SCHEMBL2405752 0.81 RECQL (0.60) MEN1KMT2AARKDM4EALDH1A1
SCHEMBL1198026 0.81 MEN1 (0.52) MEN1KMT2AARKDM4EALDH1A1
SCHEMBL2493641 0.80 ALOX5 (0.58) MEN1KMT2AKDM4EALDH1A1CASP3
SCHEMBL19626577 0.79 ALDH1A1 (0.53) MEN1KMT2AARKDM4EALDH1A1
SCHEMBL9955922 0.79 KDM4E (0.68) MEN1KMT2AKDM4EALDH1A1IDO1
SCHEMBL9955024 0.78 CYP19A1 (0.67) CFTRIDO1RAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102256972-A Thiazolyl-benzimidazoles HOFFMANN LA ROCHE 2011-11-23 CN disclosed
EP-2379543-A2 THIAZOLYL-BENZIMIDAZOLES F. Hoffmann-La Roche AG (CH) 2011-10-26 EP disclosed
US-8044213-B2 Thiazolyl-benzimidazoles HOFFMANN-LA ROCHE INC. (US) 2011-10-25 US disclosed
WO-2010121675-A2 THIAZOLYL-BENZIMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2010-10-28 WO disclosed
US-20100160308-A1 Thiazolyl-Benzimidazoles CAI JIANPING 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160308-A1 Thiazolyl-Benzimidazoles CYP3A7, CYP2C19, CYP3A5 MEN1 557/4885KMT2A 3383/4885AR 1620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.